COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Paraglide HF

Purpose of Study

To assess the effect of in-hospital initiation of sacubitril/valsartan in patients with HFpEF who have been stabilized during hospitalization for acute decompensated heart failure, elevated NT-proBNP or BNP during current hospitalization

Trial Status

Enrolling

Eligibility Criteria

40 years of age or older, currently hospitalized with acute decompensated HFpEF

Duration of Participation

Approximately 18 weeks

Contact Name: Megan Murphy, RN

Contact Phone: 515-235-5089

Contact Email: memurphy@iowaheart.com